Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $95

Morgan Stanley maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $90 to $95.

Benzinga · 11/13/2019 13:12

Morgan Stanley maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $90 to $95.